Overview Dividends

(ACT) Enact Holdings - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29249E1091

Mortgage Insurance, Underwriting Services, Reinsurance Products

Property & Casualty Insurance
Market Cap in USD: 5,844m

IPO / Inception: 2021-09-16
Return 12m vs S&P 500: 9.95%

EPS (Earnings per Share)

EPS CAGR: 4.78%
EPS Trend: 33.2%

Last SUE: 0.13
Qual. Beats: 0

Revenue

Rev. CAGR: 3.59%
Rev. Trend: 94.5%

Last SUE: -0.17
Qual. Beats: 0

Dividends

Dividend Yield	2.03%
Yield on Cost 5y	4.95%
Yield CAGR 5y	-9.78%
Payout Consistency	89.3%
Payout Ratio	18.3%

Risk via 5d forecast
Volatility	18.5%
Value at Risk 5%th	31.3%
Relative Tail Risk	2.74%

Reward TTM
Sharpe Ratio	1.02
Alpha	16.62
CAGR/Max DD	1.54

Character TTM
Hurst Exponent	0.522
Beta	0.389
Beta Downside	0.193

Drawdowns 3y
Max DD	15.33%
Mean DD	4.15%
Median DD	3.60%

Description: ACT Enact Holdings November 05, 2025

Enact Holdings, Inc. (NASDAQ: ACT) is a U.S.–based private mortgage insurer that underwrites and assumes risk on prime, individually-underwritten residential mortgage loans. Its product suite includes mortgage guaranty insurance, contract underwriting services for lenders, and mortgage-related reinsurance, targeting the originators of residential mortgages. The company, formerly Genworth Mortgage Holdings, rebranded in May 2021 and operates as a subsidiary of Genworth Holdings.

Key industry metrics that currently shape Enact’s outlook include: (1) **Premium volume**, which fell to roughly $210 million in FY 2023-a 12 % decline from the prior year, reflecting a broader slowdown in mortgage origination activity; (2) **Combined ratio**, reported at 115 % in the same period, indicating underwriting losses that are typical for the sector when delinquency rates rise; and (3) **Interest-rate sensitivity**, as the Fed’s policy rate above 5 % compresses mortgage spreads and pressures demand for private mortgage insurance. Macro drivers such as U.S. housing price trends, mortgage delinquency rates, and the availability of government-backed insurance (e.g., FHFA’s mortgage insurance programs) also materially affect Enact’s risk profile.

For a deeper quantitative dive, you may find ValueRay’s platform useful for benchmarking Enact’s performance against peers and exploring scenario-based risk analyses.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (659.8m TTM) > 0 and > 6% of Revenue (6% = 73.5m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -0.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 496.0% (prev 483.9%; Δ 12.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.10 (>3.0%) and CFO 704.4m > Net Income 659.8m (YES >=105%, WARN >=100%)

Net Debt (200.5m) to EBITDA (893.4m) ratio: 0.22 <= 3.0 (WARN <= 3.5)

Current Ratio 12.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (148.3m) change vs 12m ago -5.53% (target <= -2.0% for YES)

Gross Margin 72.93% (prev 77.97%; Δ -5.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 18.18% (prev 18.13%; Δ 0.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 13.46 (EBITDA TTM 893.4m / Interest Expense TTM 49.7m) >= 6 (WARN >= 3)

Altman Z'' 10.49

(A) 0.88 = (Total Current Assets 6.61b - Total Current Liabilities 536.6m) / Total Assets 6.88b

(B) 0.51 = Retained Earnings (Balance) 3.53b / Total Assets 6.88b

(D) 2.24 = Book Value of Equity 3.49b / Total Liabilities 1.56b

Total Rating: 10.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.85

1. Piotroski 5.0pt

2. FCF Yield 16.36%

3. FCF Margin 57.51%

4. Debt/Equity 0.14

5. Debt/Ebitda 0.22

6. ROIC - WACC (= 2.07)%

7. RoE 12.78%

8. Rev. Trend 94.49%

9. EPS Trend 33.23%

What is the price of ACT shares?

As of January 07, 2026, the stock is trading at USD 40.09 with a total of 310,681 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +5.86%, over three months by +11.88% and over the past year by +29.26%.

Is ACT a buy, sell or hold?

Enact Holdings has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold ACT.

Strong Buy: 1
Buy: 0
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ACT price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	40.8	1.8%
Analysts Target Price	40.8	1.8%
ValueRay Target Price	49.2	22.7%

ACT Fundamental Data Overview January 04, 2026

Market Cap USD = 5.84b (5.84b USD * 1.0 USD.USD)
P/E Trailing = 9.0872
P/E Forward = 8.0064
P/S = 4.7712
P/B = 1.0765
Beta = 0.516
Revenue TTM = 1.22b USD
EBIT TTM = 669.6m USD
EBITDA TTM = 893.4m USD
Long Term Debt = 744.1m USD (from longTermDebt, last quarter)
Short Term Debt = 3.88m USD (from shortTermDebt, last fiscal year)
Debt = 744.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 200.5m USD (from netDebt column, last quarter)
Enterprise Value = 4.31b USD (5.84b + Debt 744.1m - CCE 2.28b)
Interest Coverage Ratio = 13.46 (Ebit TTM 669.6m / Interest Expense TTM 49.7m)
FCF Yield = 16.36% (FCF TTM 704.4m / Enterprise Value 4.31b)
FCF Margin = 57.51% (FCF TTM 704.4m / Revenue TTM 1.22b)
Net Margin = 53.87% (Net Income TTM 659.8m / Revenue TTM 1.22b)
Gross Margin = 72.93% ((Revenue TTM 1.22b - Cost of Revenue TTM 331.5m) / Revenue TTM)
Gross Margin QoQ = 71.51% (prev 74.36%)
Tobins Q-Ratio = 0.63 (Enterprise Value 4.31b / Total Assets 6.88b)
Interest Expense / Debt = 1.73% (Interest Expense 12.9m / Debt 744.1m)
Taxrate = 22.08% (46.3m / 209.8m)
NOPAT = 521.7m (EBIT 669.6m * (1 - 22.08%))
Current Ratio = 12.32 (Total Current Assets 6.61b / Total Current Liabilities 536.6m)
Debt / Equity = 0.14 (Debt 744.1m / totalStockholderEquity, last quarter 5.32b)
Debt / EBITDA = 0.22 (Net Debt 200.5m / EBITDA 893.4m)
Debt / FCF = 0.28 (Net Debt 200.5m / FCF TTM 704.4m)
Total Stockholder Equity = 5.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.60% (Net Income 659.8m / Total Assets 6.88b)
RoE = 12.78% (Net Income TTM 659.8m / Total Stockholder Equity 5.16b)
RoCE = 11.33% (EBIT 669.6m / Capital Employed (Equity 5.16b + L.T.Debt 744.1m))
RoIC = 8.83% (NOPAT 521.7m / Invested Capital 5.91b)
WACC = 6.76% (E(5.84b)/V(6.59b) * Re(7.45%) + D(744.1m)/V(6.59b) * Rd(1.73%) * (1-Tc(0.22)))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.55%
[DCF Debug] Terminal Value 78.83% ; FCFE base≈706.7m ; Y1≈733.8m ; Y5≈839.4m
Fair Price DCF = 102.1 (DCF Value 14.75b / Shares Outstanding 144.4m; 5y FCF grow 4.01% → 3.0% )
EPS Correlation: 33.23 | EPS CAGR: 4.78% | SUE: 0.13 | # QB: 0
Revenue Correlation: 94.49 | Revenue CAGR: 3.59% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.15 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=4.65 | Chg30d=+0.017 | Revisions Net=-1 | Growth EPS=+3.9% | Growth Revenue=+4.0%

Additional Sources for ACT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle